Literature DB >> 22820867

Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.

Albert Ferrés-Coy1, Noemí Santana, Anna Castañé, Roser Cortés, María C Carmona, Miklos Toth, Andrés Montefeltro, Francesc Artigas, Analía Bortolozzi.   

Abstract

RATIONALE: Identifying the etiological factors in anxiety and depression is critical to develop more efficacious therapies. The inhibitory serotonin(1A) receptors (5-HT(1A)R) located on 5-HT neurons (autoreceptors) limit antidepressant responses and their expression may be increased in treatment-resistant depressed patients.
OBJECTIVES: Recently, we reported that intranasal administration of modified small interference RNA (siRNA) molecules targeting 5-HT(1A)R in serotonergic neurons evoked antidepressant-like effects. Here we extended this finding using marketed siRNAs against 5-HT(1A)R (1A-siRNA) to reduce directly the 5-HT(1A) autoreceptor expression and evaluate its biological consequences under basal conditions and in response to stressful situations.
METHODS: Adult mice were locally infused with vehicle, nonsense siRNA, and 1A-siRNA into dorsal raphe nucleus (DR). 5-HT(1A)R knockout mice (1A-KO) were also used. Histological approaches, in vivo microdialysis, and stress-related behaviors were performed to assess the effects of 5-HT(1A) autoreceptor knockdown.
RESULTS: Intra-DR 1A-siRNA infusion selectively reduced 5-HT(1A)R mRNA and binding levels and canceled 8-OH-DPAT-induced hypothermia. Basal extracellular 5-HT in medial prefrontal cortex (mPFC) did not differ among treatments. However, 1A-siRNA-treated mice displayed less immobility in the tail suspension and forced swim tests, as did 1A-KO mice. This was accompanied by a greater increase in prefrontal 5-HT release during tail suspension test. Moreover, intra-DR 1A-siRNA infusion augmented the increase of extracellular 5-HT in mPFC evoked by fluoxetine, up to the level in 1A-KO mice.
CONCLUSION: Together with our previous report, the present results indicate that acute suppression of 5-HT(1A) autoreceptor expression evokes robust antidepressant-like effects, likely mediated by an increased capacity of serotonergic neurons to release 5-HT in stressful conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820867     DOI: 10.1007/s00213-012-2795-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

Review 1.  Autoregulation of serotonin neurons: role in antidepressant drug action.

Authors:  G Piñeyro; P Blier
Journal:  Pharmacol Rev       Date:  1999-09       Impact factor: 25.468

2.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Authors:  Cornelius Gross; Xiaoxi Zhuang; Kimberly Stark; Sylvie Ramboz; Ronald Oosting; Lynn Kirby; Luca Santarelli; Sheryl Beck; René Hen
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

3.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

4.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

5.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.

Authors:  Analía Bortolozzi; Mercè Amargós-Bosch; Miklos Toth; Francesc Artigas; Albert Adell
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

7.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding.

Authors:  M Pompeiano; J M Palacios; G Mengod
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

8.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

9.  Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression.

Authors:  C D Neff; V Abkevich; J C L Packer; Y Chen; J Potter; R Riley; C Davenport; J DeGrado Warren; S Jammulapati; A Bhathena; W S Choi; P E Kroeger; R E Metzger; A Gutin; M H Skolnick; D Shattuck; D A Katz
Journal:  Mol Psychiatry       Date:  2008-02-12       Impact factor: 15.992

10.  Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.

Authors:  Bao-jian Li; Qingquan Tang; Du Cheng; Chuan Qin; Frank Y Xie; Qiang Wei; Jun Xu; Yijia Liu; Bo-jian Zheng; Martin C Woodle; Nanshan Zhong; Patrick Y Lu
Journal:  Nat Med       Date:  2005-08-21       Impact factor: 53.440

View more
  27 in total

Review 1.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

2.  A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors.

Authors:  Katherine M Nautiyal; Laurent Tritschler; Susanne E Ahmari; Denis J David; Alain M Gardier; René Hen
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

3.  Blunted 5-HT1A receptor-mediated responses and antidepressant-like behavior in mice lacking the GABAB1a but not GABAB1b subunit isoforms.

Authors:  Laura H Jacobson; Daniel Hoyer; Dominique Fehlmann; Bernhard Bettler; Klemens Kaupmann; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2017-01-09       Impact factor: 4.530

4.  Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder.

Authors:  Francesc Artigas; Analia Bortolozzi
Journal:  Neuropsychopharmacology       Date:  2017-01       Impact factor: 7.853

5.  Facilitation of serotonin signaling by SSRIs is attenuated by social isolation.

Authors:  Elyse C Dankoski; Kara L Agster; Megan E Fox; Sheryl S Moy; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2014-07-01       Impact factor: 7.853

6.  Activation of postsynaptic 5-HT1A receptors improve stress adaptation.

Authors:  Jiansong Zhou; Xia Cao; Adam C Mar; Yu-Qiang Ding; Xiaoping Wang; Qi Li; Lingjiang Li
Journal:  Psychopharmacology (Berl)       Date:  2013-11-21       Impact factor: 4.530

Review 7.  Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior.

Authors:  Stefanie C Altieri; Alvaro L Garcia-Garcia; E David Leonardo; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2012-12-20       Impact factor: 4.418

Review 8.  Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

Authors:  Pau Celada; Analía Bortolozzi; Francesc Artigas
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

9.  The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy Controls.

Authors:  R Seiger; G Gryglewski; M Klöbl; A Kautzky; G M Godbersen; L Rischka; T Vanicek; M Hienert; J Unterholzner; L R Silberbauer; P Michenthaler; P Handschuh; A Hahn; S Kasper; R Lanzenberger
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-23       Impact factor: 5.176

10.  RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.

Authors:  A Ferrés-Coy; F Pilar-Cuellar; R Vidal; V Paz; M Masana; R Cortés; M C Carmona; L Campa; A Pazos; A Montefeltro; E M Valdizán; F Artigas; A Bortolozzi
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.